Frank Schweizer

Affiliations: 
Chemistry University of Manitoba, Winnipeg, Manitoba, Canada 
Area:
Organic Chemistry
Google:
"Frank Schweizer"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Nachtigal MW, Musaphir P, Dhiman S, et al. (2021) Cytotoxic capacity of a novel glycosylated antitumor ether lipid in chemotherapy-resistant high grade serous ovarian cancer in vitro and in vivo. Translational Oncology. 14: 101203
Zhanel GG, Deng C, Zelenitsky S, et al. (2020) Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia. Drugs
Idowu T, Ammeter D, Brizuela M, et al. (2020) Overcoming β-Lactam resistance in Pseudomonas aeruginosa using non-canonical tobramycin-based antibiotic adjuvants. Bioorganic & Medicinal Chemistry Letters. 30: 127575
Ramirez D, Berry L, Domalaon R, et al. (2020) Dilipid Ultrashort Tetrabasic Peptidomimetics Potentiate Novobiocin and Rifampicin Against Multidrug-Resistant Gram-Negative Bacteria. Acs Infectious Diseases
Ogunsina M, Samadder P, Idowu T, et al. (2020) Syntheses of L-Rhamnose-Linked Amino Glycerolipids and Their Cytotoxic Activities against Human Cancer Cells. Molecules (Basel, Switzerland). 25
Zhanel GG, Esquivel J, Zelenitsky S, et al. (2020) Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent. Drugs
Idowu T, Zhanel GG, Schweizer F. (2020) A Dimer, but not Monomer, of Tobramycin Potentiates Ceftolozane against MDR/XDR and Delays Resistance Development. Antimicrobial Agents and Chemotherapy
Nachtigal MW, Schweizer F, Arthur G. (2020) Abstract A56: Novel L-sugar linked glycosylated antitumor ether lipids for killing platinum-resistant human epithelial ovarian cancer cells Clinical Cancer Research. 26
Islam R, Singh V, Ammeter D, et al. (2020) Electrochemical characterization of the antibiotic hybrid ciprofloxacin-tobramycin Electrochemistry Communications. 119: 106825
Idowu T, Ammeter D, Rossong H, et al. (2019) Homodimeric Tobramycin Adjuvant Repurposes Novobiocin as an Effective Antibacterial Agent against Gram-negative Bacteria. Journal of Medicinal Chemistry
See more...